Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Understanding what to look for in financial planning tools is crucial. Discover essential features that can help you achieve your financial goals.
23,175 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Institutional moves can reveal where smart money sees durable cash flow. Learn why ancora advisors opens $148 million...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Cloud giants and AI pioneers are driving a wave of data-center investment. We break down three stock picks that could...
In uncertain times, one reliable approach is to target recession-resistant dividend stocks. This article shines a lig...
Hedge funds linked to Millennium Management are expanding IVV positions as markets wobble, intensifying chatter aroun...
PayPal’s collapsing stock price is harming YieldMax’s PYPY ETF, where income from options premiums no longer keeps pa...
Lands' End is at a crossroads as it approaches 2025 earnings. This guide breaks down what to watch, how to model pote...
Berkshire Hathaway sits on a massive stock portfolio and a mountain of cash. As leadership quietly shifts, investors ...
Oil prices rebounded today, lifting energy stocks. ExxonMobil led gains as the market priced in stronger cash flow, s...
FuboTV has endured a brutal stretch as it tries to monetize a changing sports-media world. This deep dive weighs whet...
Investors noticed a meaningful rebound in Jumia’s growth metrics, nudging the stock higher. This article breaks down ...